Showing 1 - 10 of 16
Oped, Postbag, Published on 08/05/2024
» Re: "Astra jab blood clots 'rare' insists institute", (BP, May 4). One in 10 million in Thailand and one in 100,000 in the UK? How can the National Vaccine Institute possibly reconcile such a large sigma statistical anomaly and claim the risk of vaccine-induced blood clots is extremely rare in Thailand while it is criminally deadly in the UK? Worldwide, young people have been harmed and have died from blood clots -- a phenomenon that has never before been seen in these huge numbers.
Oped, Postbag, Published on 12/11/2022
» Re: "Financial injustice" and "What a cop out", (PostBag, Nov 11).
Oped, Postbag, Published on 16/09/2022
» Re: "House votes down bill on cannabis and hemp", (BP, Sept 14).
News, Postbag, Published on 14/08/2022
» Re: "Lift antiviral drug curbs," (Editorial, Aug 8).
Business, Published on 28/02/2022
» Healthcare companies that came up with effective Covid-19 vaccines, treatments and tests are seeing a huge financial payoff and are starting to spend their cash, while grappling with questions about whether the growth is sustainable.
Gary Boyle, Published on 09/11/2021
» The Ministry of Public Health wants to buy two types of oral antiviral medicines to fight Covid-19.
Business, Published on 28/09/2021
» There has never been a time when the US drugmaker and vaccine manufacturer Pfizer's purpose of "breakthroughs that change patients' lives" has been more fitting than in the midst of the Covid-19 pandemic.
News, Published on 14/09/2021
» Schools will resume on-site learning in November, provided that sufficient vaccines are made available for students next month, the Education Ministry has said.
Oped, Postbag, Published on 20/08/2021
» Re: "Why more Sinovac?," (Editorial, Aug 18).
Oped, Postbag, Published on 09/07/2021
» Re: "Anti-vaxxer overload," (PostBag, July 3).